Home

Atlas of Colposcopy: Principles and Practice

Filter by language: English / 中文 / Français / Español / Português

Early and advanced cancers / Squamous cell cancer
Go back to the list    

  

  • Age: 54
  • HPV status: Positive


  • After normal saline

    After normal saline

    After acetic acid

    After acetic acid

    After acetic acid with green filter

    After Lugol’s iodine

    Colposcopy report (2011 IFCPC nomenclature):
    / Post-treatment consequence / Endometriosis

    General assessment
  • Adequacy:
  • Squamocolumnar junction visibility:
  • Transformation zone:

  • Normal colposcopic findings
  • Original squamous epithelium:
  • Columnar epithelium:
  • Metaplastic squamous epithelium:
  • Deciduosis in pregnancy:

  • Abnormal colposcopic findings
    General principles
    Position and size
  • Location of the lesion:
  • Location of the lesion by clock position:
  • No. of quadrants:
  • % of cervix:

  • Grade 1 (minor)

    Grade 2 (major)

    Non-specific

    Suspicious for invasion

    Miscellaneous finding



    Swede score:

    Swede score
    0
    1
    2
    Aceto uptake
    Nil or transparentThin, milkyDistinct, stearin
    Margins
    Nil or diffuseSharp but irregular, jagged, satellitesSharp and even, difference in level
    Vessels
    Fine, regularAbsentCoarse or atypical vessels
    Lesion size
    < 5 mm5-15 mm or 2 quadrants>15 mm, 3-4 quadrants, or endocervically undefined
    Iodine uptake
    BrownFaintly or patchy yellowDistinctly yellow

    Final Swede score: 10



    Case Summary
    Provisional diagnosis: Type 3 transformation zone; high-grade squamous intraepithelial lesion (HSIL).
     
    Management: LLETZ (type 3 excision).
     
    Histopathology: Invasive squamous cell carcinoma.
     
    Comment: Extension of lesion to the vagina often indicates the presence of invasive disease. Diagnostic excision was performed, which revealed invasive disease. The patient was finally treated with radical hysterectomy with pelvic lymphadenectomy.


      
    25 avenue Tony Garnier CS 90627 69366, LYON CEDEX 07 France - Tel: +33 (0)4 72 73 84 85
    © IARC 2024 - Terms of use  -  Privacy Policy.